Oncocyte Corporation announced that Ronnie Andrews will step down from his role as a director of the company's board of directors, effective December 1, 2022. In order to ensure a smooth transition effective as of December 2, 2022, and Mr. Andrews will continue to act a consultant until February 28, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 USD | +1.72% | +4.98% | +18.00% |
May. 15 | Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M | MT |
Apr. 25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.00% | 39.43M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.43% | 22.27B | |
-12.64% | 22.22B | |
-5.20% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Announces Step Down of Ronnie Andrews as Board of Directors, Effective December 1, 2022